{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:28Z","timestamp":1785894808177,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102851"],"award-info":[{"award-number":["82102851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04566-0","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:04:06Z","timestamp":1780319046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-assembled nanoplatform for synergistic anti-angiogenic\/photothermal therapy against gastric cancer with Src-mediated pathway blocking"],"prefix":"10.1186","volume":"24","author":[{"given":"Lingling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"4566_CR1","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun TI, Younus S, Rahman MH. Gastric cancer-epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review. Cancer Treat Res Commun. 2024;41:100845.","journal-title":"Cancer Treat Res Commun"},{"key":"4566_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study. EClinicalMedicine. 2022;47:101404.","journal-title":"EClinicalMedicine"},{"key":"4566_CR3","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"4566_CR4","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00535-022-01884-6","volume":"57","author":"H Tanaka","year":"2022","unstructured":"Tanaka H, Kanda M, Shimizu D, Tanaka C, Inokawa Y, Hattori N, et al. Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy. J Gastroenterol. 2022;57:640\u201353.","journal-title":"J Gastroenterol"},{"key":"4566_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10:627\u201342.","journal-title":"Trends Cancer"},{"key":"4566_CR6","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S1470-2045(22)00603-9","volume":"23","author":"ZA Wainberg","year":"2022","unstructured":"Wainberg ZA, Enzinger PC, Kang YK, Qin S, Yamaguchi K, Kim IH, et al. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol. 2022;23:1430\u201340.","journal-title":"Lancet Oncol"},{"key":"4566_CR7","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20201004","volume":"95","author":"W Sun","year":"2022","unstructured":"Sun W, Li G, Zhang J, Zhu J, Zhang Z. The role of nutritional assessment for predicting radiotherapy-induced adverse events in patients with gastric cancer. Br J Radiol. 2022;95:20201004.","journal-title":"Br J Radiol"},{"key":"4566_CR8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182\u20136.","journal-title":"N Engl J Med"},{"key":"4566_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298\u2013307.","journal-title":"Nature"},{"key":"4566_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26:313\u201347.","journal-title":"Angiogenesis"},{"key":"4566_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58\u201362.","journal-title":"Science"},{"key":"4566_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","volume":"20","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Adjei AA. Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor. Oncologist. 2015;20:660\u201373.","journal-title":"Oncologist"},{"key":"4566_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","volume":"22","author":"Y Cao","year":"2023","unstructured":"Cao Y, Langer R, Ferrara N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat Rev Drug Discov. 2023;22:476\u201395.","journal-title":"Nat Rev Drug Discov"},{"key":"4566_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17:657\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"4566_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102295","volume":"56","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Zhang H, Zhang W, Zhang Y, Cui Y, Mei L, et al. Smart platelet-based biohybrid delivery system for magnetic-guided targeted delivery and enhanced photothermal-chemo therapy against glioma. Nano Today. 2024;56:102295.","journal-title":"Nano Today"},{"key":"4566_CR16","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","volume":"17","author":"M Overchuk","year":"2023","unstructured":"Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17:7979\u20138003.","journal-title":"ACS Nano"},{"key":"4566_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123340","volume":"321","author":"Y Feng","year":"2025","unstructured":"Feng Y, Ni J, Xie H, Zhu N, Liu W, Guo L, et al. NIR-II AIEgen with high photothermal efficiency for mild PTT: optimized natural killer cell spatial distribution for boosted immune response. Biomaterials. 2025;321:123340.","journal-title":"Biomaterials"},{"key":"4566_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202201486","volume":"61","author":"D Wei","year":"2022","unstructured":"Wei D, Huang Y, Wang B, Ma L, Karges J, Xiao H. Photo-reduction with NIR light of nucleus-targeting Pt(IV) nanoparticles for combined tumor-targeted chemotherapy and photodynamic immunotherapy. Angew Chem Int Ed Engl. 2022;61:e202201486.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4566_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202304312","volume":"62","author":"J Cheng","year":"2023","unstructured":"Cheng J, Zhu Y, Dai Y, Li L, Zhang M, Jin D, et al. Gas-mediated tumor energy remodeling for sensitizing mild photothermal therapy. Angew Chem Int Ed Engl. 2023;62:e202304312.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4566_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2025.100090","volume":"4","author":"J Wu","year":"2025","unstructured":"Wu J, Zhang G, Zou M, Huang Q, Zhang Y, Sui Y, et al. \u201cGreen\u201d gas-generation strategy to combine cancer phototherapy for remarkably enhanced efficacy. Nano TransMed. 2025;4:100090.","journal-title":"Nano TransMed"},{"key":"4566_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230163","volume":"4","author":"S Liang","year":"2024","unstructured":"Liang S, Liu Y, Zhu H, Liao G, Zhu W, Zhang L. Emerging nitric oxide gas-assisted cancer photothermal treatment. Exploration. 2024;4:20230163.","journal-title":"Exploration"},{"key":"4566_CR22","doi-asserted-by":"publisher","first-page":"15344","DOI":"10.1073\/pnas.1411499111","volume":"111","author":"L Tang","year":"2014","unstructured":"Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, et al. Investigating the optimal size of anticancer nanomedicine. Proc Natl Acad Sci U S A. 2014;111:15344\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4566_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101119","volume":"27","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, He J, Zhang H, Chi H, Shi Y, Xu X. Recent advances in the development of tumor microenvironment-activatable nanomotors for deep tumor penetration. Mater Today Bio. 2024;27:101119.","journal-title":"Mater Today Bio"},{"key":"4566_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","volume":"20","author":"C Viallard","year":"2017","unstructured":"Viallard C, Larriv\u00e9e B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20:409\u201326.","journal-title":"Angiogenesis"},{"key":"4566_CR25","first-page":"144","volume":"5","author":"Y Ai","year":"2024","unstructured":"Ai Y, Tian Y, Qiao J, Wang C, Li H. \u201cYin-Yang philosophy\u201d for the design of anticancer drug delivery nanoparticles. Biomater Transl. 2024;5:144\u201356.","journal-title":"Biomater Transl"},{"key":"4566_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2018.1515609","volume":"15","author":"WK Martins","year":"2019","unstructured":"Martins WK, Santos NF, Rocha CS, Bacellar IOL, Tsubone TM, Viotto AC, et al. Parallel damage in mitochondria and lysosomes is an efficient way to photoinduce cell death. Autophagy. 2019;15:259\u201379.","journal-title":"Autophagy"},{"key":"4566_CR27","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1038\/sj.onc.1203912","volume":"19","author":"RB Irby","year":"2000","unstructured":"Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene. 2000;19:5636\u201342.","journal-title":"Oncogene"},{"key":"4566_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jso.23416","volume":"108","author":"C Schildberg","year":"2013","unstructured":"Schildberg C, Abbas M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, et al. COX-2, TFF1, and Src define better prognosis in young patients with gastric cancer. J Surg Oncol. 2013;108:409\u201313.","journal-title":"J Surg Oncol"},{"key":"4566_CR29","doi-asserted-by":"publisher","first-page":"47931","DOI":"10.18632\/oncotarget.18201","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wu N, Pang B, Tong D, Sun D, Sun H, et al. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK\/Src and ERK pathways. Oncotarget. 2017;8:47931\u201342.","journal-title":"Oncotarget"},{"key":"4566_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omto.2022.03.004","volume":"25","author":"X Huang","year":"2022","unstructured":"Huang X, Lai S, Qu F, Li Z, Fu X, Li Q, et al. CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6\/Src\/PI3K\/Akt pathway. Mol Ther Oncolytics. 2022;25:1\u201315.","journal-title":"Mol Ther Oncolytics"},{"key":"4566_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10120-022-01279-9","volume":"25","author":"L He","year":"2022","unstructured":"He L, Feng A, Guo H, Huang H, Deng Q, Zhao E, et al. LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC\/STAT3\/VEGFA pathway. Gastric Cancer. 2022;25:527\u201341.","journal-title":"Gastric Cancer"},{"key":"4566_CR32","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1021\/bi0100586","volume":"40","author":"G Tian","year":"2001","unstructured":"Tian G, Cory M, Smith AA, Knight WB. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines. Biochemistry. 2001;40:7084\u201391.","journal-title":"Biochemistry"},{"key":"4566_CR33","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/ijc.22410","volume":"120","author":"S Donnini","year":"2007","unstructured":"Donnini S, Monti M, Castagnini C, Solito R, Botta M, Schenone S, et al. Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling. Int J Cancer. 2007;120:995\u20131004.","journal-title":"Int J Cancer"},{"key":"4566_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"ZN Lei","year":"2022","unstructured":"Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther. 2022;7:358.","journal-title":"Signal Transduct Target Ther"},{"key":"4566_CR35","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1021\/acs.bioconjchem.0c00356","volume":"31","author":"S Lei","year":"2020","unstructured":"Lei S, Zhang Y, Blum NT, Huang P, Lin J. Recent advances in croconaine dyes for bioimaging and theranostics. Bioconjug Chem. 2020;31:2072\u201384.","journal-title":"Bioconjug Chem"},{"key":"4566_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biomaterials.2017.03.009","volume":"129","author":"L Tang","year":"2017","unstructured":"Tang L, Zhang F, Yu F, Sun W, Song M, Chen X, et al. Croconaine nanoparticles with enhanced tumor accumulation for multimodality cancer theranostics. Biomaterials. 2017;129:28\u201336.","journal-title":"Biomaterials"},{"key":"4566_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02695-y","volume":"22","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wang H, Zhang X, Ding Y, Zou Y, Wang J, et al. Croconaine-based NIR-II fluorescence imaging-guided tumor photothermal therapy induces long-term antitumor immune memory. J Nanobiotechnology. 2024;22:481.","journal-title":"J Nanobiotechnology"},{"key":"4566_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02133-5","volume":"21","author":"Y Dong","year":"2023","unstructured":"Dong Y, Xia P, Xu X, Shen J, Ding Y, Jiang Y, et al. Targeted delivery of organic small-molecule photothermal materials with engineered extracellular vesicles for imaging-guided tumor photothermal therapy. J Nanobiotechnology. 2023;21:442.","journal-title":"J Nanobiotechnology"},{"key":"4566_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202402993","volume":"20","author":"L Luo","year":"2024","unstructured":"Luo L, Li C, Wang Y, Chen P, Zhou Z, Chen T, et al. Multi-functional 2D covalent organic frameworks with diketopyrrolopyrrole as electron acceptor. Small. 2024;20:e2402993.","journal-title":"Small"},{"key":"4566_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2025.102737","volume":"63","author":"S Yang","year":"2025","unstructured":"Yang S, Chen R, Hua P, Wu Y, Chen M. Integrating autophagy inhibition and ROS clearance in biohybrid nanoparticles for low-temperature cancer photothermal therapy. Nano Today. 2025;63:102737.","journal-title":"Nano Today"},{"key":"4566_CR41","doi-asserted-by":"publisher","first-page":"10904","DOI":"10.1021\/acsnano.2c03222","volume":"16","author":"R Zhao","year":"2022","unstructured":"Zhao R, Zhu Y, Zhou J, Liu B, Du Y, Gai S, et al. Dual glutathione depletion enhanced enzyme catalytic activity for hyperthermia assisted tumor therapy on semi-metallic VSe(2)\/Mn-CS. ACS Nano. 2022;16:10904\u201317.","journal-title":"ACS Nano"},{"key":"4566_CR42","first-page":"4","volume":"6","author":"X Li","year":"2025","unstructured":"Li X, Guan Y, Li C, Cheng H, Bai J, Zhao J, et al. Recent advances in mitochondrial transplantation to treat disease. Biomater Transl. 2025;6:4\u201323.","journal-title":"Biomater Transl"},{"key":"4566_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0076-6879(08)01409-2","volume":"442","author":"S Ivanova","year":"2008","unstructured":"Ivanova S, Repnik U, Bojic L, Petelin A, Turk V, Turk B. Lysosomes in apoptosis. Methods Enzymol. 2008;442:183\u201399.","journal-title":"Methods Enzymol"},{"key":"4566_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.01.003","volume":"94","author":"R Roskoski Jr.","year":"2015","unstructured":"Roskoski R Jr. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors. Pharmacol Res. 2015;94:9\u201325.","journal-title":"Pharmacol Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04566-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04566-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:31:03Z","timestamp":1785893463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04566-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4566"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04566-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Acquisition of the donor tumor tissues and adjacent normal tissues, and the following experimental procedures were approved by the Ethics Committee of Anhui Medical University (Date: 1st March 2024; Approval number: 83241260). All the donors have provided written consent for the usage of the donor tissue in scientific research. All animal experiments were performed in accordance with the regulations on animal experimentation and approved by the ethics committee of Anhui Medical University (Date: 1st March 2021; Approval number: 20210901).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"719"}}